Drawing Strength From Music
Music can play a powerful role in helping patients find strength and comfort both during and after treatment. In this…
04/12/2022
Drawing Strength From Music
Music can play a powerful role in helping patients find strength and comfort both during and after treatment. In this…
|
03/21/2022
Life After Loss: Lisa Huntley’s Life Has Come Full Circle
by Mara Klecker Lisa Huntley remembers walking out of the hospital without her husband, Grant, in 1994 and thinking to…
|
|
03/19/2022
FDA Approves Opdualag (nivolumab and relatlimab-rmbw) Fixed-Dose Combination as Treatment for Patients with Unresectable or Metastatic Melanoma
CONTACT: Samantha Guild President AIM at Melanoma Foundation 916/206-6100 SGuild@AIMatMelanoma.org March 19, 2022 (Richmond, California) Yesterday, Bristol Myers Squibb announced…
|
03/09/2022
Building Psychological Resilience in the Face of Hereditary Risk
Living with hereditary cancer risk can be extremely stressful for all cancer patients. In this episode, Dr. Karen Hurley shares…
|
02/09/2022
Conversations About Immunotherapy and Caregiving
In this episode, Dr. Ray Liu and Melissa Wilson, PA-C, MPAS, Melanoma Lead at UPMC Hillman Cancer Center, and AIM’s…
|
01/27/2022
President’s Letter | January 2022
From the Desk of Samantha Guild Happy 2022! I hope this year is joyful and healthy for you and…
|
01/27/2022
In Plain English: The Results of DreamSeq
By Kim Margolin, M.D., FACP, FASCO Patients with advanced melanoma—spread to other organs or grown too large in the lymph…
|
01/26/2022
One Survivor Finds Empowerment through Education and Supporting Others
By Mara Klecker Ann Marie received her first-ever physical in 2019 at the age of 53. She’d lost her father…
|
01/26/2022
Become a Member of the Supporters Guild
“How Can I Help?” Fortunately for AIM, so many of you call or write us and ask this question. And…
|
01/26/2022
FDA Approves KIMMTRAK (tebentafusp-tebn) for the Treatment of Unresectable or Metastatic Uveal Melanoma
January 26, 2022 (Richmond, California) Earlier today, Immunocore announced that the U.S. Food and Drug Administration (FDA) has approved KIMMTRAK…
|
Recent Posts
Jul. 06, 2026
How Melanoma Changed Adam Harper’s Perspective on Life
Jun. 26, 2026
FDA Accepts Review of RP1 for Advanced Melanoma; Decision Expected August 2026
Jun. 23, 2026
Insights from the 2026 American Academy of Dermatology (AAD) Annual Practice Safe Sun Survey
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient—What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 09, 2026